nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4D—TSH signaling pathway—RBL2—ocular cancer	0.0751	0.0751	CbGpPWpGaD
Roflumilast—PDE4D—TSH signaling pathway—CCND3—ocular cancer	0.0598	0.0598	CbGpPWpGaD
Roflumilast—PDE4D—TSH signaling pathway—GNAQ—ocular cancer	0.0425	0.0425	CbGpPWpGaD
Roflumilast—PDE4C—G Protein Signaling Pathways—GNA11—ocular cancer	0.0399	0.0399	CbGpPWpGaD
Roflumilast—PDE4C—G Protein Signaling Pathways—GNAQ—ocular cancer	0.0371	0.0371	CbGpPWpGaD
Roflumilast—PDE4D—G Protein Signaling Pathways—GNA11—ocular cancer	0.0348	0.0348	CbGpPWpGaD
Roflumilast—PDE4A—G Protein Signaling Pathways—GNA11—ocular cancer	0.0331	0.0331	CbGpPWpGaD
Roflumilast—PDE4D—G Protein Signaling Pathways—GNAQ—ocular cancer	0.0323	0.0323	CbGpPWpGaD
Roflumilast—PDE4D—TSH signaling pathway—E2F1—ocular cancer	0.0315	0.0315	CbGpPWpGaD
Roflumilast—PDE4A—G Protein Signaling Pathways—GNAQ—ocular cancer	0.0308	0.0308	CbGpPWpGaD
Roflumilast—PDE4B—G Protein Signaling Pathways—GNA11—ocular cancer	0.0306	0.0306	CbGpPWpGaD
Roflumilast—PDE4B—G Protein Signaling Pathways—GNAQ—ocular cancer	0.0285	0.0285	CbGpPWpGaD
Roflumilast—PDE4D—TSH signaling pathway—CDK2—ocular cancer	0.0272	0.0272	CbGpPWpGaD
Roflumilast—PDE4D—TSH signaling pathway—CDK4—ocular cancer	0.0257	0.0257	CbGpPWpGaD
Roflumilast—PDE4D—TSH signaling pathway—RB1—ocular cancer	0.0223	0.0223	CbGpPWpGaD
Roflumilast—PDE4D—Myometrial Relaxation and Contraction Pathways—GNAQ—ocular cancer	0.0215	0.0215	CbGpPWpGaD
Roflumilast—PDE4B—Myometrial Relaxation and Contraction Pathways—GNAQ—ocular cancer	0.0189	0.0189	CbGpPWpGaD
Roflumilast—PDE4D—TSH signaling pathway—CDKN1B—ocular cancer	0.0174	0.0174	CbGpPWpGaD
Roflumilast—PDE4D—TSH signaling pathway—MYC—ocular cancer	0.0133	0.0133	CbGpPWpGaD
Roflumilast—PDE4D—TSH signaling pathway—HRAS—ocular cancer	0.0105	0.0105	CbGpPWpGaD
Roflumilast—PDE4D—TSH signaling pathway—AKT1—ocular cancer	0.00923	0.00923	CbGpPWpGaD
Roflumilast—PDE4C—G Protein Signaling Pathways—HRAS—ocular cancer	0.00913	0.00913	CbGpPWpGaD
Roflumilast—PDE4D—G Protein Signaling Pathways—HRAS—ocular cancer	0.00795	0.00795	CbGpPWpGaD
Roflumilast—PDE4A—G Protein Signaling Pathways—HRAS—ocular cancer	0.00756	0.00756	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SAG—ocular cancer	0.00735	0.00735	CbGpPWpGaD
Roflumilast—PDE4B—G Protein Signaling Pathways—HRAS—ocular cancer	0.007	0.007	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—GNA11—ocular cancer	0.00651	0.00651	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—E2F5—ocular cancer	0.0065	0.0065	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SAG—ocular cancer	0.0064	0.0064	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—E2F4—ocular cancer	0.00637	0.00637	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RBL1—ocular cancer	0.00625	0.00625	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SAG—ocular cancer	0.00609	0.00609	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—GNAQ—ocular cancer	0.00605	0.00605	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—GNA11—ocular cancer	0.00591	0.00591	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—GNA11—ocular cancer	0.00566	0.00566	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—E2F5—ocular cancer	0.00566	0.00566	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SAG—ocular cancer	0.00563	0.00563	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—E2F4—ocular cancer	0.00555	0.00555	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—GNAQ—ocular cancer	0.00549	0.00549	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RBL1—ocular cancer	0.00544	0.00544	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—E2F3—ocular cancer	0.00542	0.00542	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—GNA11—ocular cancer	0.00539	0.00539	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—E2F5—ocular cancer	0.00539	0.00539	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—E2F4—ocular cancer	0.00528	0.00528	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—GNAQ—ocular cancer	0.00527	0.00527	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RBL1—ocular cancer	0.00518	0.00518	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—GNA11—ocular cancer	0.00514	0.00514	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TFDP1—ocular cancer	0.00504	0.00504	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—GNAQ—ocular cancer	0.00501	0.00501	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—GNA11—ocular cancer	0.00499	0.00499	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—E2F5—ocular cancer	0.00499	0.00499	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—GNA11—ocular cancer	0.0049	0.0049	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—E2F4—ocular cancer	0.00488	0.00488	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RBL1—ocular cancer	0.00479	0.00479	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—GNAQ—ocular cancer	0.00478	0.00478	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—E2F3—ocular cancer	0.00472	0.00472	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—GNAQ—ocular cancer	0.00464	0.00464	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—GNAQ—ocular cancer	0.00455	0.00455	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—GNA11—ocular cancer	0.00453	0.00453	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—E2F3—ocular cancer	0.00449	0.00449	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TFDP1—ocular cancer	0.00438	0.00438	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—GNAQ—ocular cancer	0.00421	0.00421	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TFDP1—ocular cancer	0.00417	0.00417	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—E2F3—ocular cancer	0.00415	0.00415	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MAML2—ocular cancer	0.004	0.004	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TFDP1—ocular cancer	0.00386	0.00386	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GNA11—ocular cancer	0.00349	0.00349	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MAML2—ocular cancer	0.00348	0.00348	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MAML2—ocular cancer	0.00331	0.00331	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GNAQ—ocular cancer	0.00324	0.00324	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MAML2—ocular cancer	0.00307	0.00307	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GNA11—ocular cancer	0.00304	0.00304	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HDAC1—ocular cancer	0.00292	0.00292	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GNA11—ocular cancer	0.00289	0.00289	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GNAQ—ocular cancer	0.00282	0.00282	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GNAQ—ocular cancer	0.00269	0.00269	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GNA11—ocular cancer	0.00268	0.00268	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CDKN2B—ocular cancer	0.00262	0.00262	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HDAC1—ocular cancer	0.00255	0.00255	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GNAQ—ocular cancer	0.00249	0.00249	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HDAC1—ocular cancer	0.00242	0.00242	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—E2F1—ocular cancer	0.00241	0.00241	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CDKN2B—ocular cancer	0.00228	0.00228	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HDAC1—ocular cancer	0.00224	0.00224	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CDKN2B—ocular cancer	0.00217	0.00217	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—E2F1—ocular cancer	0.00209	0.00209	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CDKN2B—ocular cancer	0.00201	0.00201	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—E2F1—ocular cancer	0.00199	0.00199	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—E2F1—ocular cancer	0.00185	0.00185	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MDM2—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HRAS—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CDKN1B—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—AKT1—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCND1—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MDM2—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CDKN1A—ocular cancer	0.00123	0.00123	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MDM2—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—AKT1—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HRAS—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—EP300—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CDKN1B—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—AKT1—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HRAS—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MDM2—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCND1—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CDKN1B—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—AKT1—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CDKN1A—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCND1—ocular cancer	0.00105	0.00105	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—AKT1—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HRAS—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CDKN1B—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MYC—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CDKN1A—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—EP300—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TGFB1—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—AKT1—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—AKT1—ocular cancer	0.000988	0.000988	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCND1—ocular cancer	0.000971	0.000971	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—EP300—ocular cancer	0.000966	0.000966	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CDKN1A—ocular cancer	0.00094	0.00094	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—AKT1—ocular cancer	0.000915	0.000915	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—EP300—ocular cancer	0.000894	0.000894	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MYC—ocular cancer	0.000885	0.000885	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TGFB1—ocular cancer	0.000882	0.000882	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MYC—ocular cancer	0.000842	0.000842	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TGFB1—ocular cancer	0.00084	0.00084	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TP53—ocular cancer	0.000835	0.000835	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HRAS—ocular cancer	0.000798	0.000798	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MYC—ocular cancer	0.000779	0.000779	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TGFB1—ocular cancer	0.000777	0.000777	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TP53—ocular cancer	0.000726	0.000726	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKT1—ocular cancer	0.000705	0.000705	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HRAS—ocular cancer	0.000695	0.000695	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TP53—ocular cancer	0.000691	0.000691	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HRAS—ocular cancer	0.000661	0.000661	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TP53—ocular cancer	0.00064	0.00064	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKT1—ocular cancer	0.000613	0.000613	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HRAS—ocular cancer	0.000612	0.000612	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKT1—ocular cancer	0.000584	0.000584	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKT1—ocular cancer	0.00054	0.00054	CbGpPWpGaD
